Literature DB >> 15205946

Crosstalk of oncogenic and prostanoid signaling pathways.

Rolf Müller1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15205946     DOI： 10.1007/s00432-004-0570-y

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN： 0171-5216            Impact factor:   4.553


× No keyword cloud information.
  195 in total

Review 1.  Cyclooxygenases: structural, cellular, and molecular biology.

Authors:  W L Smith; D L DeWitt; R M Garavito
Journal:  Annu Rev Biochem       Date:  2000       Impact factor: 23.643

2.  Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site.

Authors:  M Adams; M J Reginato; D Shao; M A Lazar; V K Chatterjee
Journal:  J Biol Chem       Date:  1997-02-21       Impact factor: 5.157

3.  Inhibition of COX-2 and induction of apoptosis: two determinants of nonsteroidal anti-inflammatory drugs' chemopreventive efficacies in mouse lung tumorigenesis.

Authors:  R Yao; N Rioux; A Castonguay; M You
Journal:  Exp Lung Res       Date:  2000-12       Impact factor: 2.459

4.  Stromal production of prostacyclin confers an antiapoptotic effect to colonic epithelial cells.

Authors:  N Shane Cutler; Ramona Graves-Deal; Bonnie J LaFleur; Zhenqiang Gao; Bruce M Boman; Robert H Whitehead; Erin Terry; Jason D Morrow; Robert J Coffey
Journal:  Cancer Res       Date:  2003-04-15       Impact factor: 12.701

5.  Inhibitors of cyclooxygenase-2 (COX-2) suppressed the proliferation and differentiation of human leukaemia cell lines.

Authors:  Y Nakanishi; R Kamijo; K Takizawa; M Hatori; M Nagumo
Journal:  Eur J Cancer       Date:  2001-08       Impact factor: 9.162

6.  Anticancer effects of thiazolidinediones are independent of peroxisome proliferator-activated receptor gamma and mediated by inhibition of translation initiation.

Authors:  S S Palakurthi; H Aktas; L M Grubissich; R M Mortensen; J A Halperin
Journal:  Cancer Res       Date:  2001-08-15       Impact factor: 12.701

7.  Sodium butyrate inhibits angiogenesis of human intestinal microvascular endothelial cells through COX-2 inhibition.

Authors:  Hitoshi Ogawa; Parvaneh Rafiee; Pamela J Fisher; Nathan A Johnson; Mary F Otterson; David G Binion
Journal:  FEBS Lett       Date:  2003-11-06       Impact factor: 4.124

8.  Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II.

Authors:  J E Dinchuk; B D Car; R J Focht; J J Johnston; B D Jaffee; M B Covington; N R Contel; V M Eng; R J Collins; P M Czerniak
Journal:  Nature       Date:  1995-11-23       Impact factor: 49.962

9.  Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis.

Authors:  Karin Muller-Decker; Gitta Neufang; Irina Berger; Melanie Neumann; Friedrich Marks; Gerhard Furstenberger
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-09       Impact factor: 11.205

Review 10.  Therapeutic potential of selective cyclooxygenase-2 inhibitors in the management of tumor angiogenesis.

Authors:  Stephen Gately; Robert Kerbel
Journal:  Prog Exp Tumor Res       Date:  2003
View more
  13 in total

1.  Kinetic insulation as an effective mechanism for achieving pathway specificity in intracellular signaling networks.

Authors:  Marcelo Behar; Henrik G Dohlman; Timothy C Elston
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-03       Impact factor: 11.205

Review 2.  Mechanisms of drug combinations: interaction and network perspectives.

Authors:  Jia Jia; Feng Zhu; Xiaohua Ma; Zhiwei Cao; Zhiwei W Cao; Yixue Li; Yixue X Li; Yu Zong Chen
Journal:  Nat Rev Drug Discov       Date:  2009-02       Impact factor: 84.694

Review 3.  In-silico approaches to multi-target drug discovery : computer aided multi-target drug design, multi-target virtual screening.

Authors:  Xiao Hua Ma; Zhe Shi; Chunyan Tan; Yuyang Jiang; Mei Lin Go; Boon Chuan Low; Yu Zong Chen
Journal:  Pharm Res       Date:  2010-03-11       Impact factor: 4.200

4.  Long signaling cascades tend to attenuate retroactivity.

Authors:  Hamid R Ossareh; Alejandra C Ventura; Sofia D Merajver; Domitilla Del Vecchio
Journal:  Biophys J       Date:  2011-04-06       Impact factor: 4.033

Review 5.  Synergy and antagonism in natural product extracts: when 1 + 1 does not equal 2.

Authors:  Lindsay K Caesar; Nadja B Cech
Journal:  Nat Prod Rep       Date:  2019-06-19       Impact factor: 13.423

6.  Modeling evolution of crosstalk in noisy signal transduction networks.

Authors:  Ammar Tareen; Ned S Wingreen; Ranjan Mukhopadhyay
Journal:  Phys Rev E       Date:  2018-02       Impact factor: 2.529

7.  Peroxisome proliferator-activated receptor beta/delta expression and activation in lung cancer.

Authors:  Tetyana V Pedchenko; Adriana L Gonzalez; DingZhi Wang; Raymond N DuBois; Pierre P Massion
Journal:  Am J Respir Cell Mol Biol       Date:  2008-06-19       Impact factor: 6.914

Review 8.  Recent advances of cocktail chemotherapy by combination drug delivery systems.

Authors:  Quanyin Hu; Wujin Sun; Chao Wang; Zhen Gu
Journal:  Adv Drug Deliv Rev       Date:  2015-11-06       Impact factor: 15.470

9.  β-Catenin and peroxisome proliferator-activated receptor-δ coordinate dynamic chromatin loops for the transcription of vascular endothelial growth factor A gene in colon cancer cells.

Authors:  Injoo Hwang; Jeeho Kim; Sunjoo Jeong
Journal:  J Biol Chem       Date:  2012-10-18       Impact factor: 5.157

10.  What does it take to synergistically combine sub-potent natural products into drug-level potent combinations?

Authors:  Chu Qin; Kai Leng Tan; Cun Long Zhang; Chun Yan Tan; Yu Zong Chen; Yu Yang Jiang
Journal:  PLoS One       Date:  2012-11-28       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.